FI86253B - Syntetiskt, plasmafritt, transfusibelt foervaringsmedium foer blodplaettar. - Google Patents

Syntetiskt, plasmafritt, transfusibelt foervaringsmedium foer blodplaettar.

Info

Publication number
FI86253B
FI86253B FI875063A FI875063A FI86253B FI 86253 B FI86253 B FI 86253B FI 875063 A FI875063 A FI 875063A FI 875063 A FI875063 A FI 875063A FI 86253 B FI86253 B FI 86253B
Authority
FI
Finland
Prior art keywords
grams
transfusibelt
foervaringsmedium
blodplaettar
foer
Prior art date
Application number
FI875063A
Other languages
English (en)
Other versions
FI86253C (fi
FI875063A0 (fi
FI875063A (fi
Inventor
Stein Holme
Original Assignee
American Nat Red Cross
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Nat Red Cross filed Critical American Nat Red Cross
Publication of FI875063A0 publication Critical patent/FI875063A0/fi
Publication of FI875063A publication Critical patent/FI875063A/fi
Publication of FI86253B publication Critical patent/FI86253B/fi
Application granted granted Critical
Publication of FI86253C publication Critical patent/FI86253C/fi

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2496/00—Reference solutions for assays of biological material
    • G01N2496/80—Multi-analyte reference solutions containing cholesterol, glucose and the like
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physiology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
FI875063A 1986-03-19 1987-11-16 Syntetiskt, plasmafritt, transfusibelt foervaringsmedium foer blodplaettar. FI86253C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US06/841,435 US4695460A (en) 1986-03-19 1986-03-19 Synthetic, plasma-free, transfusible platelet storage medium
US84143586 1986-03-19
US8700062 1987-01-20
PCT/US1987/000062 WO1987005468A1 (en) 1986-03-19 1987-01-20 Synthetic, plasma-free, transfusible platelet storage medium

Publications (4)

Publication Number Publication Date
FI875063A0 FI875063A0 (fi) 1987-11-16
FI875063A FI875063A (fi) 1987-11-16
FI86253B true FI86253B (fi) 1992-04-30
FI86253C FI86253C (fi) 1992-08-10

Family

ID=25284882

Family Applications (1)

Application Number Title Priority Date Filing Date
FI875063A FI86253C (fi) 1986-03-19 1987-11-16 Syntetiskt, plasmafritt, transfusibelt foervaringsmedium foer blodplaettar.

Country Status (16)

Country Link
US (1) US4695460A (fi)
EP (2) EP0266363A1 (fi)
JP (1) JPH07121841B2 (fi)
KR (1) KR920005684B1 (fi)
AT (1) ATE51999T1 (fi)
AU (1) AU589086B2 (fi)
BR (1) BR8706207A (fi)
CA (1) CA1299110C (fi)
DE (1) DE3762299D1 (fi)
FI (1) FI86253C (fi)
IE (1) IE60063B1 (fi)
IL (1) IL81708A0 (fi)
NZ (1) NZ219399A (fi)
WO (1) WO1987005468A1 (fi)
ZA (1) ZA871365B (fi)
ZW (1) ZW4387A1 (fi)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5176921A (en) * 1983-05-02 1993-01-05 Diamond Scientific Co. Method of blood component decontamination by glucose addition
US4828976A (en) * 1983-12-29 1989-05-09 Thomas Jefferson University Glucose free media for storing blood platelets
US4961928A (en) * 1986-03-19 1990-10-09 American Red Cross Synthetic, plasma-free, transfusible storage medium for red blood cells and platelets
US5248506A (en) * 1986-03-19 1993-09-28 American National Red Cross Synthetic, plasma-free, transfusible storage medium for red blood cells and platelets
US4944918A (en) * 1988-01-15 1990-07-31 Becton, Dickinson And Company Sterilization of blood component separation devices
US4994367A (en) * 1988-10-07 1991-02-19 East Carolina University Extended shelf life platelet preparations and process for preparing the same
US5573940A (en) * 1989-06-12 1996-11-12 Oklahoma Medical Research Foundation Cells expressing high levels of CD59
US5135916A (en) * 1989-06-12 1992-08-04 Oklahoma Medical Research Foundation Inhibition of complement mediated inflammatory response
US4925665A (en) * 1989-06-22 1990-05-15 Thomas Jefferson University Glucose free primary anticoagulant for blood containing citrate ions
US5089146A (en) 1990-02-12 1992-02-18 Miles Inc. Pre-storage filtration of platelets
US5236716A (en) * 1990-02-12 1993-08-17 Miles Inc. Platelets concentrate with low white blood cells content
EP0509083B1 (en) * 1990-11-07 1997-07-16 Baxter International Inc. Red blood cell storage solution
US5569579A (en) * 1991-04-01 1996-10-29 Thomas Jefferson University Synthetic-based platelet storage media
US5376524A (en) * 1991-04-01 1994-12-27 Thomas Jefferson University Platelet storage medium containing acetate and phosphate
US5256571A (en) * 1991-05-01 1993-10-26 Cytyc Corporation Cell preservative solution
US5474891A (en) * 1991-10-30 1995-12-12 Thomas Jefferson University Plasma-based platelet concentrate preparations with additive
US5234808A (en) * 1991-10-30 1993-08-10 Thomas Jefferson University Acetate addition to platelets stored in plasma
US5344752A (en) * 1991-10-30 1994-09-06 Thomas Jefferson University Plasma-based platelet concentrate preparations
US5328821A (en) * 1991-12-12 1994-07-12 Robyn Fisher Cold and cryo-preservation methods for human tissue slices
US5709991A (en) * 1992-03-02 1998-01-20 Cerus Corporation Proralen inactivation of microorganisms and psoralen removal
AU4677993A (en) * 1992-08-07 1994-03-03 Steritech, Inc. Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen
US5459030A (en) * 1992-03-02 1995-10-17 Steritech, Inc. Synthetic media compositions for inactivating bacteria and viruses in blood preparations with 8-methoxypsoralen
US5618662A (en) * 1992-03-02 1997-04-08 Cerus Corporation Intravenous administration of psoralen
AU4107396A (en) 1992-03-02 1996-06-06 Cerus Corporation Synthetic media for blood components
DE69332756T2 (de) * 1992-05-29 2004-02-19 University Of North Carolina At Chapel Hill Im immobilisierten zustand getrocknete pharmazeutische verträgliche menschliche blutplättchen
US5494590A (en) * 1992-06-11 1996-02-27 Becton Dickinson Method of using anticoagulant solution in blood separation
CA2101610A1 (en) * 1992-08-07 1994-02-08 William D. Prevatt Production of bacillus entomotoxins in methylotrophic yeast
DE4230513C1 (de) * 1992-09-11 1994-03-31 Fresenius Ag Vorrichtung zur Entfernung von Aluminiumionen aus Blut und Lösung zur Verwendung in der Vorrichtung
EP0744892B1 (en) 1994-12-16 2003-12-03 Baxter International Inc. Anticoagulant compositions for platelets
DE19634313A1 (de) * 1996-08-24 1998-02-26 Behringwerke Ag Methode zur Stabilisierung von Plättchen
US5906744A (en) * 1997-04-30 1999-05-25 Becton Dickinson And Company Tube for preparing a plasma specimen for diagnostic assays and method of making thereof
US7166568B1 (en) 1998-02-09 2007-01-23 Oklahoma Medical Research Foundation Compositions and methods to inhibit formation of the C5b-9 complex of complement
US6258577B1 (en) 1998-07-21 2001-07-10 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using endogenous alloxazine or isoalloxazine photosensitizers
US7498156B2 (en) 1998-07-21 2009-03-03 Caridianbct Biotechnologies, Llc Use of visible light at wavelengths of 500 to 550 nm to reduce the number of pathogens in blood and blood components
US6277337B1 (en) 1998-07-21 2001-08-21 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using photosensitizers
US7049110B2 (en) 1998-07-21 2006-05-23 Gambro, Inc. Inactivation of West Nile virus and malaria using photosensitizers
US6413713B1 (en) 1998-10-30 2002-07-02 Hyperbaric Systems Method for preserving blood platelets
JP2002538185A (ja) * 1999-03-11 2002-11-12 ハイパーベイリック システムズ 血小板を保存するための組成物及び方法
CA2334887C (en) * 1999-04-12 2012-01-24 Harvest Technologies Corporation Method and apparatus for producing platelet rich plasma and/or platelet concentrate
US7094378B1 (en) 2000-06-15 2006-08-22 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using photosensitizers
US7220747B2 (en) 1999-07-20 2007-05-22 Gambro, Inc. Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer
US6268120B1 (en) 1999-10-19 2001-07-31 Gambro, Inc. Isoalloxazine derivatives to neutralize biological contaminants
WO2001058266A1 (en) * 2000-02-10 2001-08-16 The Regents Of The University Of California Therapeutic platelets and methods
US6770478B2 (en) 2000-02-10 2004-08-03 The Regents Of The University Of California Erythrocytic cells and method for preserving cells
US7985588B2 (en) 2000-06-02 2011-07-26 Caridianbct Biotechnologies, Llc Induction of and maintenance of nucleic acid damage in pathogens using riboflavin and light
US7648699B2 (en) 2000-06-02 2010-01-19 Caridianbct Biotechnologies, Llc Preventing transfusion related complications in a recipient of a blood transfusion
TW590780B (en) 2000-06-02 2004-06-11 Gambro Inc Additive solutions containing riboflavin
US9044523B2 (en) 2000-06-15 2015-06-02 Terumo Bct, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
US6548241B1 (en) 2000-11-28 2003-04-15 Gambro, Inc. Storage solution containing photosensitizer for inactivation of biological contaminants
WO2003090793A1 (en) * 2002-04-24 2003-11-06 Gambro, Inc. Removal of adenine during a process of pathogen reducing blood and blood components
EP1562422A4 (en) * 2002-11-08 2012-04-25 Brigham & Womens Hospital COMPOSITIONS AND METHODS FOR EXTENDING THE SURVIVAL OF BLOODPLATES
WO2004093658A2 (en) * 2003-04-23 2004-11-04 Human Biosystems Improved methods and solutions for storing donor organs
US20070031812A1 (en) * 2003-06-20 2007-02-08 Pall Corporation Processing of platelet-containing biological fluids
US8835104B2 (en) * 2007-12-20 2014-09-16 Fenwal, Inc. Medium and methods for the storage of platelets
WO2010039994A2 (en) * 2008-10-01 2010-04-08 Caridianbct, Inc. Platelet additive solution for leukoreducing white blood cells in apheresed platelets
ATE500411T1 (de) * 2008-12-29 2011-03-15 Fiat Ricerche Brennstoffeinspritzsystem mit hoher betriebswiederholbarkeit und -stabilität für einen verbrennungsmotor
US20110229871A1 (en) 2010-02-16 2011-09-22 Ericson Daniel G Nucleoside-containing compositions and methods for treating red blood cells
CN106135195A (zh) 2010-02-16 2016-11-23 维亚塞尔有限责任公司 含有精氨酸的组合物和用于处理红细胞的方法
WO2012125955A2 (en) 2011-03-16 2012-09-20 Mayo Foundation For Medical Education And Research Methods and materials for prolonging useful storage of red blood cell preparations and platelet preparations
WO2012139017A1 (en) 2011-04-07 2012-10-11 Fenwal, Inc. Automated methods and systems for providing platelet concentrates with reduced residual plasma volumes and storage media for such platelet concentrates
US9788539B2 (en) 2011-05-17 2017-10-17 Velico Medical, Inc. Platelet protection solution having beta-galactosidase and sialidase inhibitors
CA2887083A1 (en) * 2012-10-05 2014-04-10 Velico Medical, Inc. Platelet additive solution having a beta-galactosidase inhibitor

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2786014A (en) * 1952-09-10 1957-03-19 James L Tullis Platelet preservation
US3629071A (en) * 1970-02-10 1971-12-21 Upjohn Co Storage-stable hemostatic transfusion suspensions of blood platelets, glucose, magnesium chloride and certain prostaglandins
GB2034463B (en) * 1978-11-11 1983-03-30 Ryan W Plaetelet reference control
US4390619A (en) * 1981-09-28 1983-06-28 James Clifford Haight Leukocyte or platelet storage using ion-exchange resins
US4489162A (en) * 1981-12-21 1984-12-18 American Hospital Supply Corporation Fresh blood (unfixed) hematology control
CA1216518A (en) * 1982-11-01 1987-01-13 Gail A. Rock Plasma-free medium for platelet storage
CA1244774A (en) * 1983-11-09 1988-11-15 Thomas Jefferson University Medium for storing blood platelets

Also Published As

Publication number Publication date
IL81708A0 (en) 1987-09-16
ATE51999T1 (de) 1990-05-15
IE60063B1 (en) 1994-05-18
EP0237863B1 (en) 1990-04-18
DE3762299D1 (de) 1990-05-23
FI86253C (fi) 1992-08-10
JPS63503381A (ja) 1988-12-08
JPH07121841B2 (ja) 1995-12-25
AU6892187A (en) 1987-10-09
KR880701072A (ko) 1988-07-25
IE870608L (en) 1987-09-19
NZ219399A (en) 1989-05-29
WO1987005468A1 (en) 1987-09-24
EP0237863A1 (en) 1987-09-23
ZW4387A1 (en) 1987-06-03
EP0266363A1 (en) 1988-05-11
KR920005684B1 (ko) 1992-07-13
ZA871365B (en) 1987-09-30
US4695460A (en) 1987-09-22
CA1299110C (en) 1992-04-21
AU589086B2 (en) 1989-09-28
FI875063A0 (fi) 1987-11-16
FI875063A (fi) 1987-11-16
BR8706207A (pt) 1988-02-23

Similar Documents

Publication Publication Date Title
FI86253B (fi) Syntetiskt, plasmafritt, transfusibelt foervaringsmedium foer blodplaettar.
DE3886006D1 (de) Synthetisches, plasmafreies, übertragbares Konservierungsmittel für rote Blutkörperchen.
DE3380112D1 (en) Plasma-free medium for platelet storage and its production
DK0772972T3 (da) Opløsning til konservering af celler
AR245566A1 (es) Composicion desinfectante de alto nivel esterilizadora, e inodora.
AU563215B2 (en) Sterilizable storage solution for red blood cells
DE3686584D1 (de) Stabilisierung von leukozyten.
ES2039215T3 (es) Compuesto inyectable de cefalosporina.
FI853962L (fi) Buffrade glutaraldehyd innehaollande steriliserande och desinficerande kompositioner.
ES482393A1 (es) Un metodo de esterilizar articulos en componentes liquidos.
GB1061336A (en) Improvements in or relating to the preservation of viable animal tissues and cells
SU1009469A1 (ru) Плазмозамещающий раствор дл хранени эритроцитов "эритроцифонит
GB1449228A (en) Conservation of blood
SE8503847D0 (sv) Behallare for sterilisering och steril lagring av foremal
UA26116C2 (uk) Спосіб консервування еритроцитів
GB1410554A (en) Thioadenosines
Ford 4954128 Therapeutics plasma exchange system

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: AMERICAN RED CROSS